Abstract:Neutrophils sense and migrate towards chemotactic factors released at sites of infection/inflammation and contain the affected area using a variety of effector mechanisms. Aside from these established immune defense functions, neutrophils are emerging as one of the key tumor-infiltrating immune cells that influence cancer progression and metastasis. Neutrophil recruitment to the tumor microenvironment (TME) is mediated by multiple mediators including cytokines, chemokines, lipids, and growth factors that are secreted from cancer cells and cancer-associated stromal cells. However, the molecular mechanisms that underlie the expression and secretion of the different mediators from cancer cells and how neutrophils integrate these signals to reach and invade tumors remain unclear. Here, we discuss the possible role of the epithelial to mesenchymal transition (EMT) program, which is a well-established promoter of malignant potential in cancer, in regulating the expression and secretion of these key mediators. We also summarize and review our current understanding of the machineries that potentially control the secretion of the mediators from cancer cells, including the exocytic trafficking pathways, secretory autophagy, and extracellular vesicle-mediated secretion. We further reflect on possible mechanisms by which different mediators collaborate by integrating their signaling network, and particularly focus on TGF-β, a cytokine that is highly expressed in invasive tumors, and CXCR2 ligands, which are crucial neutrophil recruiting chemokines. Finally, we highlight gaps in the field and the need to expand current knowledge of the secretory machineries and cross-talks among mediators to develop novel neutrophil targeting strategies as effective therapeutic options in the treatment of cancer.

A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor

Rational targeting of immunosuppressive neutrophils in cancer

Regulative Role of the CXCL13-CXCR5 Axis in the Tumor Microenvironment

CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β

Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer

Tumor-associated Neutrophils in Tumor Development and Progression

The Role of CXCR3 and Its Ligands in Cancer

Tumor-Associated Neutrophils in Cancer: Going Pro

Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases

Tumor-associated neutrophils and neutrophil-targeted cancer therapies

The Role of Cxc Chemokines and Their Receptors in the Progression and Treatment of Tumors

CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer

The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators

CXCL3: A key player in tumor microenvironment and inflammatory diseases

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies

Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy

Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy

Effect of CXCR7 on Tumor Development,Angiogenesis and Immune Reaction

The Role of Neutrophils in Cancer Development

[Neutrophils in the tumor microenvironment-foes or friends?]